BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12395373)

  • 1. Lentigo maligna and superficial spreading melanoma are different in their in situ phase: an immunohistochemical study.
    Auslender S; Barzilai A; Goldberg I; Kopolovic J; Trau H
    Hum Pathol; 2002 Oct; 33(10):1001-5. PubMed ID: 12395373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentigo maligna and malignant melanoma in situ, lentigo maligna type.
    Flotte TJ; Mihm MC
    Hum Pathol; 1999 May; 30(5):533-6. PubMed ID: 10333223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentigo maligna and lentigo maligna melanoma.
    Dallimore KJ
    J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):500. PubMed ID: 9091498
    [No Abstract]   [Full Text] [Related]  

  • 4. Unusual variants of melanoma: fact or fiction?
    Sagebiel RW
    Semin Oncol; 1996 Dec; 23(6):703-8. PubMed ID: 8970590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Expression of Cancer Testis Antigens on Lentigo Maligna and Lentigo Maligna Melanoma.
    Tio D; Willemsen M; Krebbers G; Kasiem FR; Hoekzema R; van Doorn R; Bekkenk MW; Luiten RM
    Am J Dermatopathol; 2020 Aug; 42(8):625-627. PubMed ID: 32701706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lentigo maligna and lentigo maligna melanoma: a clinicopathologic analysis of twenty-four cases].
    Ren M; Kong YY; Shen XX; Cai X; Kong JC
    Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):769-774. PubMed ID: 30317732
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of soluble adenylyl cyclase in lentigo maligna: use of immunohistochemistry with anti-soluble adenylyl cyclase antibody (R21) in diagnosis of lentigo maligna and assessment of margins.
    Magro CM; Yang SE; Zippin JH; Zembowicz A
    Arch Pathol Lab Med; 2012 Dec; 136(12):1558-64. PubMed ID: 23194049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrafacial Lentigo Maligna: A Report on 14 Cases and a Review of the Literature.
    Martínez-Leboráns L; Garcías-Ladaria J; Oliver-Martínez V; Alegre de Miquel V
    Actas Dermosifiliogr; 2016 Oct; 107(8):e57-63. PubMed ID: 27180003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reflectance confocal microscopy of facial lentigo maligna and lentigo maligna melanoma: a preliminary study.
    Ahlgrimm-Siess V; Massone C; Scope A; Fink-Puches R; Richtig E; Wolf IH; Koller S; Gerger A; Smolle J; Hofmann-Wellenhof R
    Br J Dermatol; 2009 Dec; 161(6):1307-16. PubMed ID: 19566662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for lentigo maligna melanoma compared with superficial spreading melanoma: a case-control study in Australia.
    Kvaskoff M; Siskind V; Green AC
    Arch Dermatol; 2012 Feb; 148(2):164-70. PubMed ID: 22004881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical staining with Melan-A of uninvolved sun-damaged skin shows features characteristic of lentigo maligna.
    Bowen AR; Thacker BN; Goldgar DE; Bowen GM
    Dermatol Surg; 2011 May; 37(5):657-63. PubMed ID: 21446989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular malignant melanoma: a variant of melanoma to be distinguished from lentigo maligna melanoma.
    Hantschke M; Mentzel T; Kutzner H
    Am J Dermatopathol; 2004 Oct; 26(5):359-63. PubMed ID: 15365365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A collision tumor involving Basal cell carcinoma and lentigo maligna melanoma.
    Belisle A; Gautier MS; Ghozali F; Plantier F; Wechsler J
    Am J Dermatopathol; 2005 Aug; 27(4):319-21. PubMed ID: 16121053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic Features Associated With an Invasive Component in Lentigo Maligna Lesions.
    Moreno A; Manrique-Silva E; Virós A; Requena C; Sanmartín O; Traves V; Nagore E
    JAMA Dermatol; 2019 Jul; 155(7):782-788. PubMed ID: 31066867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentigo maligna: melanoma in situ on chronically sun-damaged skin.
    Reed JA; Shea CR
    Arch Pathol Lab Med; 2011 Jul; 135(7):838-41. PubMed ID: 21732771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of proliferation- and apoptosis-related markers in lentigo maligna and solar keratosis keratinocytes.
    Feinmesser M; Tsabari C; Fichman S; Hodak E; Sulkes J; Okon E
    Am J Dermatopathol; 2003 Aug; 25(4):300-7. PubMed ID: 12876487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type.
    Swetter SM; Chen FW; Kim DD; Egbert BM
    J Am Acad Dermatol; 2015 Jun; 72(6):1047-53. PubMed ID: 25791801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentigo Maligna.
    Franke JD; Woolford KM; Neumeister MW
    Clin Plast Surg; 2021 Oct; 48(4):669-675. PubMed ID: 34503727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermal vascularity in lentigo maligna.
    Trotter MJ; Tron VA
    J Pathol; 1994 Aug; 173(4):341-5. PubMed ID: 7525908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.
    Tannous ZS; Lerner LH; Duncan LM; Mihm MC; Flotte TJ
    Hum Pathol; 2000 Jun; 31(6):705-8. PubMed ID: 10872664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.